Toxicity with Tomotherapy based Intensity Modified Radiation Therapy in Head and Neck cancers and in vivo prediction of radio-responsiveness of oropharyngeal cancers using Raman Spectroscopy.

Dr Vedang Murthy0 个研究点目标入组 70 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•?Biopsy proven Squamous cell carcinoma of the oropharynx, hypopharynx and larynx.
•?AJCC stage T1-3 ,N0-2c, M0 patients with pre treatment tumour measurements.
•?Surgery of the primary tumor limited to a biopsy.
•?Age>=18 and <=70 years
•?No prior history of therapeutic irradiation.
•?Patient willing and reliable for follow up.
•?Patients nutritional and physical condition compatible with planned therapy.
•?Signed study specific consent form.

•?T1N0 M0 of vocal chords
•?T4 tumor , N3 Nodal stages
•?Evidence of distance metastasis.
•?Previous therapeutic irradiation for head and neck cancer.
•?Active untreated infection which preclude the use of systemic chemotherapy or would interfere with completion of treatment
•?Any histopathology other than Squamous carcinoma
•?Primary nasopharyngeal cancers
•?Pregnant or lactating woman.

发起方

Dr Vedang Murthy